Article

Liquid Biopsy as an Option for Predictive Testing and Prognosis in Patients with Lung Cancer

2021-06-21

Abstract excerpt

<title>Abstract</title> <p>Background: The aim of this study was to investigate the clinical value of liquid biopsy as a primary source for variant analysis in lung cancer. In addition, we sought to characterize liquid biopsy variants and to correlate mutational load to clinical data. <h4>Methods:</h4> circulating cell-free DNA was extracted from plasma from patients with lung cancer (n=60) and controls with beni...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fd5f7d93-b208-5e76-82ea-06dfb53d2f99
DOI: 10.21203/rs.3.rs-174609/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Liquid Biopsy as an Option for Predictive Testing and Prognosis in Patients with Lung CancerDOI 10.21203/rs.3.rs-174609/v1Read

Liquid biopsy as an option for predictive testing and prognosis in patients with lung cancer.Semantic proximity Read

Liquid biopsy and its role in an advanced clinical trial for lung cancer.Semantic proximity Read

Liquid biopsy tracking of lung tumor evolutions over timeSemantic proximity Read

Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer.Semantic proximity Read

An update on liquid biopsy analysis for diagnostic and monitoring applications in non-small cell lung cancer.Semantic proximity Read

Complementing Tissue Testing with Plasma mutation Profiling Improves Therapeutic Decision Making for Lung Cancer PatientsSemantic proximity Read

Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patientsSemantic proximity Read

Clinical Utility of Liquid Diagnostic Platforms in Non-Small Cell Lung Cancer.Semantic proximity Read

The evolving role of liquid biopsy in lung cancer.Semantic proximity Read

Use of Liquid Biopsy in the Care of Patients with Non-Small Cell Lung Cancer.Semantic proximity Read

Blood-based circulating tumor DNA mutations as a diagnostic and prognostic biomarker for lung cancer.Semantic proximity Read

Detection of trace levels of circulating tumour DNA in early stage non-small cell lung cancerSemantic proximity Read